Anthony Holland’s Frequency Research: An Insightful Look at an Emerging Field

Some of the most exciting frontiers in frequency research have nothing to do with what you can hear. This article is a closer look at one of them: the real, ongoing laboratory work of a music professor turned cancer researcher, and an honest picture of exactly how far that research has come — and how far it still has to go.

Meet Anthony Holland

Anthony Holland is an Associate Professor and Director of Music at Skidmore College, and the principal investigator behind the Novobiotronics Research Lab, a nonprofit laboratory he leads alongside cancer researchers. Holland’s path here started from an unusual place for cancer research: a career in music and sound, and a fascination with the idea that specific frequencies might be able to physically affect living cells, the way an opera singer’s voice can shatter a wine glass at the right pitch [1].

That idea — resonant destruction — is the seed of Holland’s actual laboratory technique, though what it targets isn’t audible sound at all.

What the Research Actually Does

Holland’s lab uses a specialized lab device — an enclosed gas plasma antenna sometimes called a Phanotron — to deliver frequency-specific oscillating pulsed electric fields (OPEF) directly to cancer cells in a controlled setting. Using FM synthesis, Holland’s team searches for what they call a “Destructive Cancer Resonant Frequency Formant”: a precise electric-field frequency (or set of frequencies) that disrupts a specific type of cancer cell without harming healthy tissue around it [1][2].

In published, controlled experiments, frequencies in the 156,000–162,000 Hz range slowed the growth of Acute Lymphoblastic Leukemia cells, with cell death in trials averaging 25–40%, and reaching as high as 60% in some runs [2]. Related published research elsewhere in this same broader field — pulsed electric fields in oncology — has also grown into a real, active area of study; a well-known device using a related principle (Tumor Treating Fields) is already FDA-cleared for certain brain cancers, showing that electric-field-based cancer approaches are a legitimate, if still-developing, corner of oncology research [3].

A researcher working carefully with laboratory equipment in a science lab setting.

What This Isn’t — And Why That Matters

It’s worth being completely clear about what this research is not, because frequency-and-cancer claims are an area where a lot of dishonest, exploitative content circulates, and Holland’s real work deserves to be kept separate from that:

  • It’s not audible sound. The frequencies involved (over 150,000 Hz) are far above the range of human hearing (roughly 20–20,000 Hz). No tuning fork, singing bowl, music track, or app can reproduce what happens in Holland’s lab — this is direct electric-field exposure through specialized equipment, not something you listen to.
  • It’s not a treatment yet. These are in vitro (lab dish) experiments on isolated cells, not clinical trials in living patients. Holland and his collaborators have been open that translating lab results into an actual treatment is a long process, and that no large-scale treatment based on this research is available today [2].
  • It doesn’t kill all the cells. Even in the best trial results, a meaningful share of cancer cells survived — this is a promising early signal, not a cure.
  • It’s not a reason to delay real cancer care. If you or someone you love is facing a cancer diagnosis, an oncologist and your existing treatment plan are the place to be — this research is a hopeful direction for the future of medicine, not an alternative to medicine today.

Why It’s Still Worth Knowing About

None of those caveats make this research less genuinely interesting. Holland represents something rare and worth celebrating: a rigorous, methodical researcher, working through a real academic institution and a real nonprofit lab, willing to follow an unconventional idea — that specific frequencies could disrupt cancer cells — using real controlled experiments rather than testimonials. His TEDx talk, “Shattering Cancer with Resonant Frequencies,” lays out both the promise and the years of careful, incremental work behind it [4]. It’s a genuinely hopeful example of where curiosity, rigor, and an openness to unconventional questions can lead.

An abstract visualization evoking cellular structure and scientific research.

How to Support or Follow This Work

  • Follow Novobiotronics directly. Their site shares updates on the lab’s progress, published findings, and ways to support the research.
  • Watch Holland’s TEDx talk. It’s the clearest, most accessible introduction to both the science and the honest state of where the research stands.
  • Stay skeptical of anyone selling you a “frequency cancer cure” today. Legitimate researchers in this space, including Holland, are consistently honest about how early-stage this work is — that honesty is itself a good sign of credibility, and its absence elsewhere is worth noticing.

Go Deeper

Sources

  1. Futurism, “Resonant Frequency Might Be the Answer to a Less-Intrusive Cancer Treatment” — https://futurism.com/resonant-frequency-might-be-the-answer-to-a-less-intrusive-cancer-treatment
  2. Novobiotronics, research background and published results — https://novobiotronics.com/
  3. PMC, “Pulsed Electric Fields in Oncology: A Snapshot of Current Clinical Practices and Research Directions from the 4th World Congress of Electroporation” — https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340685/
  4. Sound Healing Research Foundation, “Shattering Cancer with Resonant Frequencies: Anthony Holland at TEDxSkidmoreCollege” — https://soundhealingresearchfoundation.org/shattering-cancer-with-resonant-frequencies-anthony-holland-at-tedxskidmorecollege/

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top